KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$31.6 million.

  • Ginkgo Bioworks Holdings' Cash from Operations rose 6946.31% to -$31.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$165.8 million, marking a year-over-year increase of 5049.99%. This contributed to the annual value of -$319.6 million for FY2024, which is 815.06% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Cash from Operations stood at -$31.6 million for Q3 2025, which was up 6946.31% from -$40.3 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Cash from Operations registered a high of -$5.2 million during Q3 2021, and its lowest value of -$165.5 million during Q4 2021.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Cash from Operations value was -$57.8 million (recorded in 2023), while the average stood at -$65.5 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 44175.74% in 2022, then soared by 6946.31% in 2025.
  • Ginkgo Bioworks Holdings' Cash from Operations (Quarter) stood at -$165.5 million in 2021, then soared by 36.85% to -$104.5 million in 2022, then skyrocketed by 44.68% to -$57.8 million in 2023, then increased by 26.62% to -$42.4 million in 2024, then increased by 25.52% to -$31.6 million in 2025.
  • Its last three reported values are -$31.6 million in Q3 2025, -$40.3 million for Q2 2025, and -$51.5 million during Q1 2025.